DK455286D0 - Farmaceutisk middel med langsom frigaering og fremgangsmaade til dets fremstilling - Google Patents

Farmaceutisk middel med langsom frigaering og fremgangsmaade til dets fremstilling

Info

Publication number
DK455286D0
DK455286D0 DK455286A DK455286A DK455286D0 DK 455286 D0 DK455286 D0 DK 455286D0 DK 455286 A DK455286 A DK 455286A DK 455286 A DK455286 A DK 455286A DK 455286 D0 DK455286 D0 DK 455286D0
Authority
DK
Denmark
Prior art keywords
tryptophan
pharmaceutical composition
fumaric acid
procedure
preparation
Prior art date
Application number
DK455286A
Other languages
English (en)
Other versions
DK166478B1 (da
DK455286A (da
Inventor
Yoshimitsu Iida
Shuji Sumida
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK455286D0 publication Critical patent/DK455286D0/da
Publication of DK455286A publication Critical patent/DK455286A/da
Application granted granted Critical
Publication of DK166478B1 publication Critical patent/DK166478B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK455286A 1985-09-26 1986-09-24 Farmaceutisk praeparat med langsom frigoering DK166478B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21327785 1985-09-26
JP21327785 1985-09-26

Publications (3)

Publication Number Publication Date
DK455286D0 true DK455286D0 (da) 1986-09-24
DK455286A DK455286A (da) 1987-03-27
DK166478B1 DK166478B1 (da) 1993-06-01

Family

ID=16636441

Family Applications (2)

Application Number Title Priority Date Filing Date
DK455286A DK166478B1 (da) 1985-09-26 1986-09-24 Farmaceutisk praeparat med langsom frigoering
DK108192A DK170110B1 (da) 1985-09-26 1992-08-31 Farmaceutisk præparat med langsom frigivelse og anvendelse af fumarsyre til fremstilling af præpar atet

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK108192A DK170110B1 (da) 1985-09-26 1992-08-31 Farmaceutisk præparat med langsom frigivelse og anvendelse af fumarsyre til fremstilling af præpar atet

Country Status (15)

Country Link
US (1) US5188840A (da)
EP (2) EP0386801B1 (da)
JP (1) JPH0772142B2 (da)
KR (1) KR950010145B1 (da)
AT (2) ATE62408T1 (da)
AU (1) AU587281B2 (da)
CA (1) CA1282327C (da)
DE (2) DE3678661D1 (da)
DK (2) DK166478B1 (da)
ES (1) ES2001993A6 (da)
FI (1) FI86146C (da)
HK (1) HK65393A (da)
IE (2) IE66255B1 (da)
NO (1) NO175763C (da)
SG (1) SG64993G (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117618376A (zh) * 2023-12-11 2024-03-01 江苏诺和必拓新药研发有限公司 一种尼可地尔膜控缓释片及其制备方法

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8429928U1 (de) * 1984-10-11 1986-02-13 Sträter, Fritz, 5882 Meinerzhagen Konzepthalter zur Anwendung an Schreib-, Zeichen-, Bildschirmarbeitsplätzen und dgl.
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
IT1256022B (it) * 1992-06-08 1995-11-20 Preparazioni farmaceutiche stabili di nicorandil
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5602180A (en) * 1995-03-31 1997-02-11 World Health Group Method of administering EDTA complexes
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FR2742659B1 (fr) * 1995-12-22 1998-03-13 Pf Medicament Procede de fabrication de minispheres matricielles a liberation prolongee
EP1017372A4 (en) * 1997-10-03 2006-05-24 Smithkline Beecham Corp SOLID GALENIC FORMS WITH CONTROLLED LITHIUM CARBONATE RELEASE
KR100630290B1 (ko) * 1998-05-15 2006-09-29 쥬가이 세이야쿠 가부시키가이샤 방출제어제제
AU778049B2 (en) * 1999-08-09 2004-11-11 Dainippon Sumitomo Pharma Co., Ltd. Solid preparation containing chitosan powder and process for producing the same
HK1042427A1 (zh) 1999-09-30 2002-08-16 Penwest Pharmaceuticals Co. 用於高溶度药物的持续释放基质方法
JP4757995B2 (ja) * 1999-11-10 2011-08-24 大日本住友製薬株式会社 薬物放出製剤
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
JP2004537506A (ja) 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
US6720356B2 (en) * 2001-04-20 2004-04-13 Spencer Feldman Magnesium di-potassium EDTA complex and method of administration
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
MXPA04002973A (es) 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040228918A1 (en) * 2003-01-02 2004-11-18 Chih-Ming Chen Granule modulating hydrogel system
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
DE102004039196B4 (de) * 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
AU2005330504B2 (en) 2004-09-29 2010-10-28 Harbor Biosciences, Inc. Steroid analogs and characterization and treatment methods
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2013153210A1 (en) 2012-04-13 2013-10-17 Nanoscape Ag Sustained-release formulation
CN105658211A (zh) 2013-10-07 2016-06-08 怡百克制药公司 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US12194150B2 (en) 2020-12-22 2025-01-14 Amneal Pharmaceuticals Llc Levodopa dosing regimen
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES300432A1 (es) * 1963-06-04 1964-11-16 Abbott Lab Procedimiento para producir una composición analgésica
US3577491A (en) * 1968-01-02 1971-05-04 Miles Lab Tableting
US3849558A (en) * 1969-06-03 1974-11-19 Sumitomo Chemical Co Pharmaceutical compositions having controlled gastro-intestinal absorption
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
BE759520A (fr) * 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
US3903255A (en) * 1971-05-17 1975-09-02 Rohm & Haas Effervescent potassium chloride tablet
JPS5115094B2 (da) * 1972-11-01 1976-05-14
US3993999A (en) * 1975-05-16 1976-11-23 Texas Instruments Incorporated Amplitude modulation scanning antenna system
US4021546A (en) * 1976-03-08 1977-05-03 Interx Research Corporation Pro-drug forms of digoxin and method of preparing and using same
DE2656227C2 (de) * 1976-12-11 1985-07-04 Bayer Ag, 5090 Leverkusen Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum
US4342764A (en) * 1979-05-29 1982-08-03 Ciba-Geigy Corporation Guanidine compounds, pharmaceutical compositions and use
US4406896A (en) * 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
DE3011327A1 (de) * 1980-03-24 1981-10-01 Basf Ag, 6700 Ludwigshafen 1-aroyl-2-phenylamino-2-imidazoline, ihre herstellung und verwendung
ZA823333B (da) * 1981-04-24 1983-11-14
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU191542B (en) * 1983-04-08 1987-03-30 Boehringer Ingelheim Ltd Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US4530920A (en) * 1983-11-07 1985-07-23 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
FR2588559B1 (fr) * 1985-10-11 1988-03-11 Bp Chimie Sa Procede de polymerisation ou de copolymerisation d'alpha-olefines en presence d'un systeme catalytique ziegler-natta ameliore

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117618376A (zh) * 2023-12-11 2024-03-01 江苏诺和必拓新药研发有限公司 一种尼可地尔膜控缓释片及其制备方法

Also Published As

Publication number Publication date
KR950010145B1 (ko) 1995-09-11
EP0386801B1 (en) 1994-07-20
IE81099B1 (en) 2000-03-08
DK108192A (da) 1992-08-31
FI863889A0 (fi) 1986-09-26
FI863889L (fi) 1987-03-27
IE940953L (en) 1987-03-26
NO175763C (no) 1994-12-07
JPH0772142B2 (ja) 1995-08-02
FI86146B (fi) 1992-04-15
NO175763B (no) 1994-08-29
DK166478B1 (da) 1993-06-01
DE3689983T2 (de) 1995-02-23
ES2001993A6 (es) 1988-07-01
ATE108647T1 (de) 1994-08-15
AU6273086A (en) 1987-04-02
DK170110B1 (da) 1995-05-29
DE3678661D1 (de) 1991-05-16
EP0218148A1 (en) 1987-04-15
EP0386801A2 (en) 1990-09-12
EP0218148B1 (en) 1991-04-10
CA1282327C (en) 1991-04-02
HK65393A (en) 1993-07-16
DK455286A (da) 1987-03-27
US5188840A (en) 1993-02-23
AU587281B2 (en) 1989-08-10
IE862468L (en) 1987-03-26
DK108192D0 (da) 1992-08-31
EP0386801A3 (en) 1990-11-07
IE66255B1 (en) 1995-12-27
ATE62408T1 (de) 1991-04-15
DE3689983D1 (de) 1994-08-25
JPS62149630A (ja) 1987-07-03
SG64993G (en) 1993-08-06
KR870002838A (ko) 1987-04-13
NO863796D0 (no) 1986-09-24
FI86146C (fi) 1992-07-27
NO863796L (no) 1987-03-27

Similar Documents

Publication Publication Date Title
AU587281B2 (en) Slow-release pharmaceutical agent
DE3872739D1 (de) Arzneimittel mit langsamer freisetzung.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
DK582287A (da) Middel til fremstilling af faste doseringsformer med ensartet og forsinket frigoerelse
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
NO883229D0 (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
ES2009216A6 (es) Metodo de preparar un derivado de interleucina-lalfa.
YU161891A (sh) Postupak za dobijanje farmaceutski preparata oralnu primenu sa usporenim oslobadjanjem aktivne supstance bez rastvarača
IT1221079B (it) Derivati di anilina terapeuticamente attivi,procedimento per la loro preparazione e composizioni farmaceutiche che il contengono
CA2380757A1 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
MY101266A (en) Pharmaceutical formulations
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
HUT53121A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
MY102368A (en) Solid sustained-release composition
WO2001010415B1 (en) A binder for pharmaceutical compositions
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
NZ216246A (en) 2-azabicyclo(3.3.0 -7-octene-3-carboxylic acid derivatives and pharmaceutical compositions
UA28457A (uk) Лікарський засіб "діпрацетам", що має знеболювальну та жарознижувальну дію та спосіб його одержання

Legal Events

Date Code Title Description
PUP Patent expired